Harvard Bioscience (HBIO) director Loewald received 45,872 shares
Stocks in this Quantisnow insightIndustrials
Insider transactions reported
Thomas W Loewald (director at Harvard Bioscience Inc., HBIO) reported that they received 45,872 shares on May 21, 2024. After these transactions the filing shows 295,311 shares held directly.
- Reporting person
- Loewald Thomas W
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 21, 2024 | Grant or award (A) | Common Stock1, 2 | +45,872 | - | - | 295,311 direct |
Holdings before and after
- Common Stock: 249,439 to 295,311 direct
Footnotes from the filing
- 1. Represents an award of 45,872 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025.
- 2. Includes (a) the award described in footnote (1) above and (b) 249,439 shares of common stock held by the Reporting Person.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Loewald report in this HBIO Form 4?
Thomas W Loewald (director at Harvard Bioscience Inc., HBIO) reported that they received 45,872 shares on May 21, 2024. After these transactions the filing shows 295,311 shares held directly.
How many HBIO shares does Loewald hold after this filing?
The filing shows 295,311 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for HBIO
Earlier insider filings at HBIO
- May 23, 2024Edrick Alan I was granted 45,872 shares, increasing direct ownership by 20% to 273,911 units (SEC Form 4)
- May 23, 2024Eade Katherine A. was granted 45,872 shares, increasing direct ownership by 17% to 311,126 units (SEC Form 4)
- Mar 7, 2024Cote Jennifer was granted 71,600 shares and covered exercise/tax liability with 9,920 shares, increasing direct ownership by 58% to 168,738 units (SEC Form 4)
- Mar 7, 2024Green James W was granted 429,594 shares, increasing direct ownership by 16% to 3,081,091 units (SEC Form 4)
- Jan 3, 2024Green James W covered exercise/tax liability with 211,182 shares, decreasing direct ownership by 7% to 2,651,497 units (SEC Form 4)
Quantisnow market dataNASDAQ
HBIO
Harvard Bioscience Inc.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Listed since
- 2000
Get push alerts for HBIO
Full HBIO profile on Quantisnow Follow HBIO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time